(Q43112723)

14 November 2017

Exenatide may aggravate moderate diabetic renal impairment: a case report (English)

1 reference

14 November 2017

1

Odd Erik Johansen

1 reference

14 November 2017

Rolf Whitfield

2

1 reference

PMCID

2561107

14 November 2017

language of work or name

English

0 references

publication date

15 May 2008

1 reference

British Journal of Clinical Pharmacology

14 November 2017

1 reference

14 November 2017

66

1 reference

14 November 2017

4

1 reference

14 November 2017

568-569

1 reference

Effect of renal impairment on the pharmacokinetics of exenatide

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561107

Prediction of creatinine clearance from serum creatinine

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561107

Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561107

Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561107

Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18537959

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2008.03221.X

1 reference

14 November 2017

1 reference

14 November 2017

1 reference

PMCID

2561107